Trial intelligence / Profile preview

Steroids and Heparin in Critically Ill COVID-19 Pneumonia

NCT04528888Phase 3Unknown

Start
Nov 2020
Primary completion
Jun 2021
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone injection, heparin in COVID-19 pneumonia. Status: unknown.

02

Drugs

methylprednisolone injectionheparin
03

Conditions

COVID-19 pneumonia

Beyond the preview

Go deeper on NCT04528888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04528888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call